Human biomonitoring reference values for metals and trace elements in blood and urine derived from the Canadian Health Measures Survey 2007–2013  by Saravanabhavan, Gurusankar et al.
IH
i
2
G
M
H
a
A
R
R
1
A
K
R
R
M
H
C
1
m
p
i
i
i
i
m
s
C
h
1
4ARTICLE IN PRESSG ModelJHEH-12996; No. of Pages 12
International Journal of Hygiene and Environmental Health xxx (2016) xxx–xxx
Contents lists available at ScienceDirect
International  Journal  of  Hygiene  and
Environmental Health
jo u r n al homepage: www.elsev ier .com/ locate / i jheh
uman  biomonitoring  reference  values  for  metals  and  trace  elements
n  blood  and  urine  derived  from  the  Canadian  Health  Measures  Survey
007–2013
urusankar  Saravanabhavan ∗, Kate  Werry,  Mike  Walker,  Douglas  Haines,
orie  Malowany,  Cheryl  Khoury
ealthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario, Canada
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 29 June 2016
eceived in revised form
6 September 2016
ccepted 12 October 2016
eywords:
eference values
eference intervals
etals and trace elements
uman biomonitoring
anadian Health Measures Survey
a  b  s  t  r  a  c  t
Human  biomonitoring  reference  values  are  statistical  estimates  that indicate  the  upper margin  of  back-
ground  exposure  to a given  chemical  at a given  time.  Nationally  representative  human  biomonitoring
data  on 176  chemicals,  including  several  metals  and  trace  elements,  are  available  in Canada  from  2007  to
2013 through  the Canadian  Health  Measures  Survey  (CHMS).  In this  work,  we used  a systematic  approach
based  on  the  reference  interval  concept  proposed  by  the  International  Federation  of Clinical  Chemistry
and  Laboratory  Medicine  and the International  Union  of  Pure  and  Applied  Chemistry  to  derive  reference
values  (RV95s)  for metals  and trace  elements.  These  RV95s  were  derived  for blood  and  urine matrices  in
the  general  Canadian  population  based  on  the  latest  biomonitoring  data  from  the CHMS.  Biomarkers  were
chosen based  on speciﬁc  selection  criteria,  including  widespread  detection  in  Canadians  (≥66%  detection
rate).  Reference  populations  were  created  for each  biomarker  by applying  appropriate  exclusion  criteria.
Age and  sex  were  evaluated  as possible  partitioning  criteria  and  separate  RV95s  were  derived  for  the  sub-
populations  in  cases  where  partitioning  was  deemed  necessary.  The  RV95s for metals  and  trace  elements
in  blood  ranged  from  0.18  g/L for  cadmium  in young  children  aged  3–5  years  to  7900  g/L  for  zinc  in
males  aged  20–79 years.  In the case  of urinary  biomarkers,  the RV95s ranged  from  0.17  g/L for  antimony
in  the total  population  aged  3–79  years  to 1400  mg/L  for  ﬂuoride  in adults  aged  20–79  years.  These  RV95s
represent  the  ﬁrst set  of  reference  values  for metals  and  trace  elements  in  the  general  Canadian  popula-
tion.  We compare  the  RV95s from  other  countries  where  available  and  discuss  factors  that  could  inﬂuence
such  comparisons.
©  2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC. Introduction
Human biomonitoring (HBM) is deﬁned broadly as the measure-
ent of biomarkers (parent chemical and/or its biotransformation
roducts) in human biological ﬂuids or tissues. Human biomon-
toring measures the internal dose of a chemical resulting from
ntegrated exposures from all exposure routes. It has been used
ncreasingly as a tool for quantifying human exposure to chem-
cals in order to inform public health, risk assessment, and riskPlease cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
anagement decisions (NRC, 2012).
National-level biomonitoring studies have been conducted in
everal countries including Canada, the United States, Germany,
∗ Corresponding author at: 269, Laurier Avenue West, Ottawa, Ontario K1A0K9,
anada.
E-mail address: gurusankar.saravanabhavan@hc-sc.gc.ca (G. Saravanabhavan).
ttp://dx.doi.org/10.1016/j.ijheh.2016.10.006
438-4639/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
France and the Republic of Korea (CDC, 2015a; Fréry et al., 2012;
Haines et al., 2016; Lee et al., 2012; Schulz et al., 2007). Inter-
pretation of HBM data can be performed at varying levels of
complexity. Preliminary interpretation involves statistical review
of the data to obtain descriptive statistical parameters regarding
the concentration of biomarkers, for example, arithmetic means,
geometric means, and percentiles. The International Federation of
Clinical Chemistry and Laboratory Medicine (IFCC) (Dybkoer, 1987;
PetitClerc and Solberg, 1987; Solberg, 2004; Solberg, 1987a,b;
Solberg and PetitClerc, 1988) and the International Union of Pure
and Applied Chemistry (IUPAC) (Poulson et al., 1997) developed
the concept of reference intervals along with the relevant statistical
methodologies to indicate background exposure to chemical sub-an biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
stances in a reference population. In addition, forward and reverse
dosimetry based approaches have also been used to interpret HBM
data in a health-risk based context. Biomonitoring equivalents,
derived based on forward dosimetry, have been developed for an
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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ncreasing number of substances using pharmacokinetics to relate
xternal reference doses to concentrations in blood or urine (Hays
t al., 2008). Intake estimates for chemicals have been derived
sing reverse dosimetry taking into consideration factors such as
harmacokinetics (CHAP, 2014; Koch et al., 2003; Saravanabhavan
t al., 2014). Finally, based on extensive epidemiological studies
or chemicals such as mercury and lead, tissue based guidance val-
es have been developed that relate HBM data directly to health
utcomes (Legrand et al., 2010; NRC, 2006).
As an indicator of background exposures in the general popu-
ation, reference values (RV95s) for environmental chemicals have
een derived based upon the IFCC and IUPAC reference interval
oncept. Biomonitoring data from nationally representative sur-
eys are considered appropriate to derive population-level RV95s
or chemicals (Ewers et al., 1999). The IFCC and IUPAC provided
ecommendations on constructing reference populations including
he ones listed below.
Sample selection: When a priori selection is not possible, a pos-
teriori selection may  be used by applying a set of exclusion and
partitioning criteria. Exclusion and partitioning criteria for each
biomarker are derived based on the knowledge of confounding
factors.
Sample size: The sample size of the reference population should
be large enough to include different age groups, race, ethnic-
ity and sex. The IFCC recommends a sample size of at least 120
people.
Time period: As exposure to environmental chemicals in the
general population can vary over time, use of the most recent
biomonitoring data is preferred for developing RV95s.
Exclusion criteria: These are speciﬁc factors that are not cate-
gorised as the general characteristics of the reference population.
Examples of such factors include smoking habits and fasting.
Partitioning criteria: If there is a signiﬁcant difference in RV95s
among different population segments, it is recommended to
derive separate RV95s for the subgroups.
Quality of the analytical methods: It is essential to assess the over-
all quality of the biomonitoring data in terms of the speciﬁcity
and the sensitivity (limit of detection) of the analytical methods
used, and the quality assurance/quality control procedures fol-
lowed during sampling, sample pre-treatment and instrumental
analysis.
The IFCC deﬁnes reference intervals for a clinical biomarker
ased on the 2.5th and 97.5th percentile estimates of its con-
entration in a reference population. While evaluating the CHMS
atasets, we observed that the 2.5th percentile concentration of the
iomarkers of environmental contaminants were often below their
espective limits of detection. Even in cases where the 2.5th and
7.5th percentiles were estimated, the coefﬁcient of variation was
ften too high to be published according to Statistics Canada’s pub-
ication policies (Statistics Canada, 2015, 2013, 2010). Moreover,
n terms of human exposure to environmental chemicals, people
t the upper end of the exposure distribution are considered more
ulnerable than those at the lower end and hence reference values
ased on the upper end of the distribution are more valuable in
xposure assessments.
Based on the recommendations of IFCC and IUPAC, the German
uman Biomonitoring Commission (HBM Commission) deﬁned
V95 as “the 95th percentile of the measured pollutant concen-
ration levels in the relevant matrix of the reference population. To
erive it, it is rounded off within the 95% conﬁdence interval” (HBMPlease cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
ommission, 2016). By using the 95th percentile rather than the
eometric mean or other measures of central tendency, RV95s thus
ndicates the upper margin of the current background exposure of
he general population to a given substance at a given time (Ewers PRESS
ne and Environmental Health xxx (2016) xxx–xxx
et al., 1999). The term “background exposure” indicates exposure
to chemicals through environmental sources as experienced by the
general population (CDC, 2001). The HBM Commission has devel-
oped RV95s for a number of environmental chemicals including
metals, persistent organic pollutants and emerging contaminants
in the German population (Schulz et al., 2011). Other countries
such as Brazil (Freire et al., 2015), Italy (Alimonti et al., 2011), the
Czech Republic (Batáriová et al., 2006) and the Republic of Korea
(Lee et al., 2012) have developed RV95s for selected environmen-
tal chemicals in their respective general population or population
sub-groups. However, in several instances we observed that the
deﬁnition of “reference value” is not well-articulated or details on
the methodology used for deriving RV95 lack clarity (Ewers et al.,
1999).
There are several uses for RV95s in public health. The RV95s
provide a basis for identifying individuals or sub-populations
with an increased level of exposure compared with the back-
ground general population level (Ewers et al., 1999; NRC, 2006).
The RV95 is not a bright line for exposure classiﬁcation (i.e.
high exposure vs low exposure). Rather, exceedance of RV95s in
individuals/subpopulations indicates the requirement for follow-
up to understand key exposure sources and factors that are
responsible for the increased exposure in those populations com-
pared to the background. It will also help to develop statistical
associations between increased exposure and health outcome in
sub-populations. In addition, RV95s could be used to assess tem-
poral changes in exposure to chemicals, patterns of use and the
effectiveness of actions to reduce exposure (Bevan et al., 2013).
Since an RV95 by deﬁnition represents the upper margin of back-
ground exposure, it could also be used in developing extreme
exposure cases based on worst-case scenarios in a human health
risk assessment. It should be emphasised that RV95s are statistical
estimates of biomarkers in relevant biological matrices derived to
reﬂect the level of background exposure to a given environmental
chemical. Unlike health based guidance values, RV95s do not take
into account toxicological information on biomarkers and, as such,
they can neither be used to assess health risks nor as a threshold
for clinical action on either at an individual or population level. In
addition, RV95s are deﬁned at a given time point and may  need
periodic revisions when new data become available.
Beginning in 2007, HBM data have been collected in
Canada through the Canadian Health Measures Survey (CHMS)
(Haines et al., 2016). The CHMS is a comprehensive, nationally-
representative direct health-measures survey implemented by
Statistics Canada in partnership with Health Canada and the Public
Health Agency of Canada, aimed at assessing the general health of
Canadians through household questionnaires, direct physical mea-
sures and biochemical analysis. This biennial survey covers about
96% of the general Canadian population (Tremblay et al., 2007).
Full-time members of the Canadian Forces and residents of the
three territories, reserves and other Aboriginal settlements in the
provinces, institutions and certain remote regions are excluded
(Giroux, 2007). The data collected to date in the CHMS make it pos-
sible to establish population-based HBM RV95s for a broad range of
environmental chemicals.
The purpose of this paper is to derive RV95s for metals and trace
elements in blood and urine in the Canadian population based
on the latest HBM data available from the CHMS using the ref-
erence interval concept recommended by IFCC and IUPAC. Using
an a posteriori selection approach and by applying the appropri-
ate exclusion criteria, reference populations are created for each
biomarker. Statistical criteria are used to assess whether age andan biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
sex partitioning of the reference population are required. Separate
RV95s are derived for the sub-populations in cases where partition-
ing was  deemed necessary.
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. Methods
.1. Data source
Detailed descriptions of the CHMS rationale, survey design, sam-
ling strategy, mobile examination centre operations and logistics,
s well as ethical, legal, and social issues have been published else-
here (Day et al., 2007; Haines et al., 2016).
During the survey, an interviewer visited participant homes and
dministered a household questionnaire to respondents to gather
nformation on general health status, medication use, nutrition and
ood, health behaviors, environmental factors, and socio-economic
tatus. The respondents then had a follow-up appointment at
 mobile examination centre where trained qualiﬁed personnel
ollected blood and urine specimens, took physical health measure-
ents and administered a clinic questionnaire to verify the health
tatus of the participants. Approximately 50% of the participants
ere asked to fast prior to sample collection to get population-level
stimates of some biochemical parameters (e.g. fasting glucose lev-
ls). The respondents were considered fasted if they did not eat or
rink anything except water for ≥10 h prior to the appointment;
therwise, the respondents were categorised as non-fasted. The
lood and urine samples collected in the CHMS were tested for sev-
ral measures including chronic and infectious diseases, nutrition
iomarkers, and biomarkers of environmental chemicals. The sur-
ey included biomarkers for a broad range of chemical categories
ncluding metals and trace elements, persistent organic pollutants,
ame retardants, and emerging contaminants such as phthalates,
isphenol A and triclosan (Haines et al., 2016).
Metals and trace elements were measured in both blood and
rine samples at the Institut national de santé publique du Québec
INSPQ) using validated analytical methods (Health Canada, 2015,
013b, 2010c). The laboratory carried out rigorous quality control
rotocols during the batch processing of the samples and tested
tandard reference materials or certiﬁed reference materials when
vailable. In addition, the laboratory analyzed ﬁeld blanks, repli-
ate samples, and blind quality control samples over the course
f each two year CHMS cycle to demonstrate the method per-
ormance. Moreover, INSPQ has participated in proﬁciency testing
or metals analyses in biological specimens conducted by the Ger-
an  quality assurance scheme. It should be noted that for some
etals detection rates have changed between CHMS cycles due to
hanges in analytical methodology and/or instrumentation used for
he sample analyses.
.2. Statistical analysis
The required respondent data (analytical as well as question-
aire) were obtained from the CHMS datasets collected between
007 and 2013. Statistical analysis was conducted using R (R Core
eam, 2015) and SUDAAN 10.0.1 software (RTI International, USA).
iomarker concentrations that were below the limit of detection
LOD) were assigned a value of LOD/2.
Reference populations were constructed for each biomarker
ased on a set of exclusion and partitioning criteria. Informa-
ion on age, sex, seafood and shellﬁsh consumption, and fasting
tatus were taken from the household and clinic questionnaires
atabase. Confounders that are known to inﬂuence biomarker con-
entrations were tested using univariate statistical analyses and
ncluded as exclusion criteria when deemed necessary. Only majorPlease cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
onfounders (such as smoking), based on the knowledge of point
ources of high exposure to the given biomarkers, were consid-
red so as to maintain a sample size of at least 120 in the reference
opulation. Fasting status was tested as a possible exclusion vari- PRESS
ne and Environmental Health xxx (2016) xxx–xxx 3
able for all biomarkers. In addition for arsenic and mercury species
smoking and seafood consumption were tested as possible exclu-
sion variables. For biomarkers measured in urine, participants with
urine creatinine values <0.3 g/L or >3.0 g/L were removed prior
to testing the other exclusion variables (WHO, 1996). For each
biomarker, the possible exclusion variables were tested one by one
using weighted regression on the log contaminant levels with the
exclusion variable as the single categorical dependent variable. If
the p-value for the exclusion variable was less than 0.05 then it was
considered to be signiﬁcant. Iteratively, the most signiﬁcant exclu-
sion variable was applied (for example, all fasted individuals were
removed if fasting status was  signiﬁcant) and the rest retested on
the reduced dataset, until all exclusions were applied or none was
signiﬁcant. Respondents’ smoking status was determined based on
their urinary cotinine concentration. Respondents with a urinary
cotinine concentration of <50 g/L were considered non-tobacco
users while all other respondents were classiﬁed as tobacco users
(Czoli and Hammond, 2015).
Age group (young children: 3–5 years; children: 6–19 years;
and adults: 20–79 years) and sex were considered as possible par-
tition variables. Initially, a population weighted 95th percentile
estimate of each biomarker concentration in the reference pop-
ulation was  derived. Then, the population was  partitioned by age
groups and the weighted proportion (i.e. percentage) of the popu-
lation in those partitions that exceeded the 95th percentile of the
combined population was  estimated. Partitioning decisions were
made based on these proportions following an approach similar to
Lahti’s new method (version 3 (Lahti et al., 2004)). Lahti et al. (2002)
derived partitioning cut-off values based on a two-sided conﬁdence
interval (at 2.5th and 97.5th percentiles). Since we used a one-sided
conﬁdence interval (at 95th percentile), we  computed new cut-off
values of 2.2% and 7.8% based on the same Gaussian distributional
assumptions used to derive the original cut-offs proposed by Lahti
et al. (2002). If the proportion in any of the age groups was  either
lower than 2.2% or higher than 7.8%, the reference population was
partitioned by age. Partitioning by sex was tested using the same
approach.
Within each signiﬁcant partition, the data were natural log-
transformed and extreme values were identiﬁed and removed
using Tukey’s approach (Tukey, 1977) if the data were not skewed,
or a modiﬁed Tukey’s approach (Hubert and Van der Veeken, 2008)
if the data remained skewed. This analysis was performed on the
unweighted data. Skewness was assessed using the medcouple
statistic (Brys et al., 2004), with values larger than 0.1 or smaller
than −0.1 considered to be evidence of skewness. In this process a
k value of 2.0 was used in order to be less strict in declaring obser-
vations to be extreme. Non-detects in the data can greatly impact
the skewness. Therefore, as an ad hoc measure, if there was more
than 10% non-detects in a partition, the non-detects were removed
prior to assessing skewness.
After extreme value removal, weighted 95th percentiles and
associated conﬁdence intervals were computed for each partition
and reported as RV95s. Variance estimation for all tests, models
and percentile estimates used the Balanced Repeated Replicates
(BRR) approach required by the CHMS, using the supplied boot-
strap weights. All results were rounded to two signiﬁcant ﬁgures
and assessed for data quality based on the coefﬁcient of variation
(CV) as per the CHMS guidelines (Statistics Canada, 2015, 2013,
2010). According to these guidelines, a CV > 33% for a statistical esti-
mate derived from the CHMS data is considered too high and is not
recommended for publications. When the CVs are between 16.6%
and 33.3%, the guidelines recommend interpreting the statisticalan biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
estimates with caution.
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Table  1
Metals and trace elements measured in the Canadian Health Measures Survey between 2007 and 2013, limit of detection and percent detection rates. Detection rates are
deﬁned as the percentage of the survey population having biomarker concentrations above the limit of detection (Health Canada, 2015, 2013b, 2010a,b,c).
Biomarker CASRN Matrix Limit of detection (g/L) Percent detection rate
2007–2009 2009–2011 2012–2013 2007–2009 2009–2011 2012–2013
Antimony 7440-36-0 Urine 0.02 0.02 77.6 80.0
Arsenic (total) 7440-38-2 Blood 0.2 92.8
Urine 0.5 0.7 99.8 98.0
Arsenic (V) acid 7778-39-4 Urine 0.8b 0.8b 0.5 0.8
Arsenobetainea 64436-13-1 Urine 0.8b 0.8b 51.5 51.8
Arsenocholine 71802-31-8 Urine 0.8b 0.0
Arsenous (III) acid 13464-58-9 Urine 0.8b 0.8b 24.4 26.0
Dimethylarsinic acid (DMA) 75-60-5 Urine 0.8b 0.8b 96.2 96.1
Monomethylarsonic acid (MMA) 124-58-3 Urine 0.8b 0.8b 27.0 28.5
Cadmium 7440-43-9 Blood 0.04 0.04 0.08 97.1 94.8 88.5
Urine  0.09 0.07 90.3 93.4
Cesium 7440-46-2 Urine 0.1 100
Cobalt 7440-48-4 Blood 0.04 100
Urine 0.06 93.1
Copper 7440-50-8 Blood 0.6 20 100 100
Urine 0.3 0.6 99.7 99.8
Fluoride 16984-48-8 Urine 20 20 100 100
Lead 7439-92-1 Blood 0.2 1 2 100 100 99.9
Urine  0.1 0.2 92.5 83.6
Manganese 7439-96-5 Blood 0.05 0.5 100.0 100.0
Urine 0.05 0.2 64.5 29.6
Mercury (total) 7439-97-6 Blood 0.1 0.1 0.4 88.4 84.4 63.0
Mercury (inorganic) 7439-97-6 Blood 0.4 11.9
Urine 0.1 0.2 50.4 49.6
Methylmercury 22967-92-6 Blood 0.2 81.3
Molybdenum 7439-98-7 Blood 0.1 0.1 99.9 99.8
Urine 0.1 1 100 100
Nickel 7440-02-0 Blood 0.4 0.3 93.3 88.0
Urine 0.2 0.3 96.8 95.7
Selenium 7782-49-2 Blood 8 20 100 100
Urine 6 4 99.5 99.9
Silver 7440-22-4 Blood 0.05 54.2
Urine 0.1 7.6
Thallium 7440-28-0 Urine 0.02 99.6
Tungsten 7440-33-7 Urine 0.2 34.4
Uranium 7440-61-1 Blood 0.005 0.007 7.0 1.2
Urine 0.01 0.01 13.0 15.5
Vanadium 7440-62-2 Urine 0.1 0.1 9.6 8.5
Zinc 7440-66-6 Blood 0.6 100 100 100
Urine 10 10 99.2 99.6
3 whe
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aa Arsenocholine and arsenobetaine were measured together in cycle 2 and cycle 
b Reported as g As/L.
. Results and discussion
We  have adopted the reference interval concept advocated by
he IUPAC and the IFCC to derive RV95s for metals and trace ele-
ents in the general Canadian population using HBM data from
he CHMS. Overall, 15 blood biomarkers and 25 urine biomarkers of
etals and trace elements were measured in the CHMS from 2007
o 2013. Some of these biomarkers were measured continuously
hile others were measured periodically (Table 1). The RV95s were
erived only for those biomarkers which were detected in at least
wo-thirds of Canadians (i.e. ≥66% detection rate; Table 1). In addi-
ion, we did not calculate RV95s for biomarkers that could not be
uantiﬁed individually by the analytical method used (e.g. arseno-
holine and arsenobetaine). RV95s for total mercury in blood and
norganic mercury in urine were derived due to their public health
mportance despite having low detection rates.
Shortlisted biomarker candidates and the exclusion and parti-
ioning criteria used to derive their respective RV95s are presented
n Table 2. We  derived RV95s for cobalt, manganese, total mercury
nd methylmercury in blood and for antimony, cesium, dimethy-Please cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
arsenic acid (DMA), ﬂuoride, inorganic mercury and thallium in
rine. Moreover, RV95s were derived for total arsenic, cadmium,
opper, lead, molybdenum, nickel, selenium and zinc for both blood
nd urine matrices. In Table 3, major uses, exposure route(s) andreas arsenocholine was measured separately in cycle 3.
key chronic health endpoints related to exposure to these metals
and trace elements in the general population are presented.
Univariate analysis showed that fasting signiﬁcantly affected
the concentrations of blood molybdenum (p < 0.0001), urine
molybdenum (p = 0.0013), blood zinc (p < 0.0001), urine zinc
(p < 0.0001), urine cadmium (p = 0.0008), urine copper (p = 0.0024),
urine ﬂuoride (p = 0.0491), and urine mercury (p = 0.0008). Fasting
is an artiﬁcial requirement in the CHMS rather than the normal
life style. Therefore, in order to obtain accurate national estimates
for some blood measures of the participants in the general popula-
tion, fasted individuals were excluded in the reference populations
of the above biomarkers. We  observed that smokers had signif-
icantly higher concentrations of cadmium in blood (p<0.0001)
and urine (p<0.0001). Hence, smokers were excluded from these
reference populations. Consumption of seafood (ﬁsh and/or shell-
ﬁsh >3 x per month) signiﬁcantly affected the concentrations of
total arsenic (p < 0.0001), total mercury (p < 0.0001), methylmer-
cury (p < 0.0001) in blood and total arsenic (p < 0.0001), DMA
(p = 0.0008), and mercury (inorganic) (p = 0.0008) in urine. There-
fore, individuals who ate seafood more than 3 times per monthan biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
were excluded in the reference populations of these biomarkers.
Decisions on partitioning of a reference population into sub-
groups could be achieved solely based on statistical testing.
However, Harris and Boyd (1990) noted that clinically important
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Table  2
List of selected biomarkers in blood and urine for deriving reference values based on the biomonitoring data from the Canadian Health Measures Survey. Exclusion and
partitioning criteria employed to construct reference populations are also indicated for each biomarker.
Biomarker measured Exclusion variablesa Partitioning variablesb
Biomarkers in blood
Arsenic (total) Ate seafood >3x/month Age
Cadmium >50 g/L urine cotinine Age
Cobalt
Copper Sex
Lead  Age
Manganese Age, Sex
Mercury (total) Ate seafood >3x/month Age
Methylmercury Ate seafood >3x/month Age
Molybdenum Fasted Age
Nickel
Selenium Age
Zinc  Fasted Age, Sex
Biomarkers in urine
Antimony
Arsenic (total) Ate seafood >3x/month
Dimethylarsinic acid (DMA) Ate seafood >3x/month Age
Cesium
Cadmium >50 g/L urine cotinine, Fasted Age
Copper Fasted Age
Fluoride Fasted Age
Lead  Age
Molybdenum Fasted Age
Mercury (inorganic) Fasted, Ate seafood >3x/month Age, Sex
Nickel
Selenium Age
Thallium Age
Zinc  Fasted
 were
d
c
r
t
a
c
t
d
f
p
t
c
p
p
t
p
c
t
(
t
p
t
r
9
y
a
a
(
t
a
wa Only major confounders that are known to inﬂuence biomarker concentrations
b Reference populations were tested only for age and sex partitioning.
ifferences amongst subgroups correlate well with the proportion
riteria (percentage of subgroups population that is outside the 95%
eference limits of the combined population) rather than the statis-
ical criteria. Moreover, statistical signiﬁcance among subgroups is
ffected by several factors including sample size. In general, a sufﬁ-
iently large sample size could detect even very small differences in
he biomarker concentrations between subgroups, although such
ifferences may  not hold any clinical or practical relevance. There-
ore, we believe the proportion criteria are more appropriate for
artitioning of the reference population. Using this methodology
he reference populations of total arsenic, cadmium, lead, total mer-
ury, methylmercury, molybdenum and selenium in blood required
artitioning only by age groups while manganese and zinc required
artitioning by age and sex. Moreover, blood copper required parti-
ioning only by sex whereas blood cobalt and blood nickel required
artitioning neither by age nor by sex. The reference population for
admium, copper, DMA, ﬂuoride, lead, molybdenum, selenium and
hallium in urine required partitioning by age while only mercury
inorganic) required partitioning by age and sex. Finally, antimony,
otal arsenic, cesium, nickel, and zinc in urine did not require any
artitioning.
The RV95s for metals and trace elements in blood and urine for
he general Canadian population are presented in Tables 4a and 4b,
espectively. These represent the ﬁrst HBM RV95s for Canada. The
5th percentile concentration estimates for blood cadmium in
oung children, blood total mercury in young children and adults,
nd blood molybdenum in young children had CVs between 16.6%
nd 33%. Considering Statistics Canada’s data quality guidelines
Statistics Canada, 2015, 2013, 2010), the RV95s derived based onPlease cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
hese 95th percentile concentration estimates should be regarded
s provisional. For the same reason, provisional urinary RV95s
ere derived for DMA  in children, ﬂuoride in adults, and mercury tested.
(inorganic) in young children. No RV95s were derived for mercury
(inorganic) in children and adult females as the CVs were >33%.
Comparison of RV95s derived in this work with those from dif-
ferent countries is valuable as it allows for a comparison of upper
bound exposure estimates between countries. Several human
biomonitoring studies conducted in other countries report ref-
erence values for metals and trace elements in blood and urine
matrices. However, we observed that in some studies the authors
did not test the effect of major confounders on the HBM data and
reported directly the 95th percentile concentrations as reference
values (Bevan et al., 2013; Tuakuila et al., 2015). We strived to match
the characteristics of the reference populations based on which
RV95s were derived to provide reasonable comparisons. Therefore,
we selected studies that (a) used principles laid out by the IUPAC
and German HBM Commission in developing reference values; (b)
carried out statistical analysis to assess key confounding factors
(exclusion criteria) and considered partitioning the reference pop-
ulation when deemed necessary; and, (c) had a sample size of at
least 120 as stipulated by the IFCC. In addition, we have considered
only studies that were published since 1997. In Tables 5a and 5b,
RV95s for various metals and trace elements in blood and urine from
studies that met  these criteria are summarised. Many factors could
affect such comparisons including:
• Inequalities in sampling design and sample sizes. Although
IUPAC guidelines indicate a minimum sample requirement of
120 (Solberg, 1987a), we  believe that the use of population-
representative datasets provides statistically robust RV95s for
environmental chemicals.an biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
• Differences in analytical methods used for measuring metal con-
centrations in the biological matrices. Particularly, uncertainties
pertaining to the quality control/quality assurance procedures
used in different studies are challenging to evaluate.
Please cite this article in press as: Saravanabhavan, G., et al., Human biomonitoring reference values for metals and trace ele-
ments in blood and urine derived from the Canadian Health Measures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
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Table  3
Uses, major exposure routes and key chronic toxic effects related to exposure to metals and trace elements in the general population.
Chemical Major uses Major route of
exposure
Key chronic health endpoints associated
with major route of exposure
References
Antimony Industrial applications, ﬂame
retardants, additive in paint
pigment, glass and ceramic
products, pharmaceutical products
Ingestion • Effects at low environment doses
unknown
•  Inhaled antimony trioxide is classiﬁed as
a  possible human carcinogen (IARC
Group 2B)
ATSDR (1992),  Environment
Canada & Health Canada (2010)
Arsenic Manufacture of industrial
applications and processing of
glass, pigments, textiles, paper,
metal adhesives, ceramics, wood
preservatives, ammunition and
explosives
Ingestion • Respiratory, skin and cardiovascular
effects
•  Inorganic arsenic compounds are
classiﬁed as carcinogenic to humans
(IARC Group 1)
ATSDR (2007), Environment
Canada & Health Canada (1993),
Health Canada (2006), IARC (2012)
Cadmium Manufacture of batteries Non-smokers:
Ingestion
Smokers:
Inhalation (of
cigarette smoke)
• Renal effect
• Cadmium and its compounds are
classiﬁed as carcinogenic to humans
(IARC Group 1)
ATSDR (2012a), IARC (2012),
Lauwerys et al. (1994)
Cesium Few commercial uses Ingestion • Few toxicological studies of stable
cesium, but animal studies indicate low
toxicity
•  Exposure to radioisotopes of cesium
may  result in effects similar to other
ionizing radiation (reproductive,
developmental and latent cancer effects)
ATSDR (2004a)
Cobalt Industrial processes Ingestion • Essential element
• Increase in red blood cells
(polycythemia); cardiovascular effects in
chronic alcoholic beer drinkers
• Inhalation of cobalt and its compounds
are classiﬁed as possibly carcinogenic to
humans (IARC Group 2B)
Alexander (1972), ATSDR (2004b),
Environment Canada & Health
Canada (2014)
Copper Cooking utensils, coins, antifouling
paint, dental amalgams, plumbing
ﬁxtures and pipes, architectural
applications, and industrial
applications
Ingestion • Essential trace element
•  Limited evidence of adverse effects
except in individuals with underlying
disorders
ATSDR (2004c),  WHO  (2004)
Fluoride Used in many industrial
applications.
Fluoride-containing compounds
added to drinking water and dental
products
Ingestion • Dental and skeletal ﬂuorosis Health Canada (2010a), IOM (1997)
Lead Industrial products, batteries
predominantly used in the
automotive industry, construction
industry products, speciality
gasoline
Ingestion • Neurodevelopmental,
neurodegenerative, cardiovascular, renal
and reproductive effects
• Inorganic lead compounds are probably
carcinogenic to humans (IARC Group 2A)
Health Canada (2013a), IARC
(2006)
Manganese Steel production, dry-cell batteries,
ﬁreworks, matches, fertilizer,
paints, as a medical imaging agent
and in cosmetics
Ingestion • Essential element
• Exposure to moderate to high levels can
lead to neurological effects
ATSDR (2012b), Canada (2011),
Health Canada (2010b)
Mercury Phased out of most manufactured
products in Canada, but still used
in products (e.g., medical devices,
batteries, lamps, dental amalgam)
Ingestion • Neurological effects and developmental
neurotoxicity
•  Methylmercury compounds are possibly
carcinogenic to humans (IARC Group 2B)
Canada (2011), IARC (1993),
Richardson (2014), UNEP (2002)
Molybdenum Steel production, electrical
contacts, spark plugs, X-ray tubes,
ﬁlaments, screens, and grids for
radio valves, glass-to-metal seals,
nonferrous alloys, and pigments
Ingestion • Essential element
• High exposure can result in elevated uric
acid levels and gout-like symptoms
USEPA (1992), WHO  (2003)
Nickel Widespread use in industrial and
consumer products
Ingestion • Allergic reaction from dermal contact
• Ingestion of very high levels unlikely
•  Long-term oral exposure of laboratory
animals resulted in systemic effects
• Nickel compounds are carcinogenic to
humans (IARC Group 1)
ATSDR (2005a), IARC (2012)
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Table  3 (Continued)
Chemical Major uses Major route of
exposure
Key chronic health endpoints associated
with major route of exposure
References
Selenium Used in a wide variety of
manufactured and consumer
products
Ingestion • Essential element
• Selenosis
ATSDR (2003), Environment
Canada & Health Canada (2015)
Thallium Industrial processes, speciﬁc
applications (e.g., cardiac imaging,
electroplating)
Ingestion • Limited information available; may
include headaches, anorexia, and pain in
the arms, thighs, and abdomen
ATSDR (2013), CCME (1999), Peter
and Viraraghavan (2005)
Zinc Galvanizing iron and steel and
other industrial processes. Zinc
compounds have wide spread use
in industrial and consumer
products.
Ingestion • Essential element
• Decreased absorption of copper leading
to hematological and gastrointestinal
effects, immunotoxicity and decreased
cholesterol levels
ATSDR (2005b), Health Canada
(1987), USEPA (2005)
Table 4a
Reference values (RV95) for metals and trace elements in blood for the general Canadian population based on human biomonitoring data from the Canadian Health Measures
Survey.
Chemical Years Group (years) N P95 (95% CI) (g/L) RV95 (g/L)
Arsenic (total) 2007–2009 6–19 875 1.4 (1.0–1.8) 1.4
2007–2009 20–79 996 2.0 (1.8–2.2) 2.0
Cadmium 2012–2013 3–5 447 0.18E (0.075–0.28) 0.18⊥
2012–2013 6–19 1793 0.27 (0.24–0.30) 0.27
2012–2013 20–79 2507 0.83 (0.72–0.95) 0.83
Cobalt 2009–2011 3–79 6009 0.38 (0.35–0.41) 0.38
Copper 2009–2011 3–79, Females 3124 1300 (1300–1400) 1300
2009–2011 3–79, Males 2940 1000 (1000–1100) 1000
Lead 2012–2013 3–5 466 20 (15–25) 20
2012–2013 6–19 1912 15 (13–16) 15
2012–2013 20–79 3142 33 (31–36) 33
Manganese 2009–2011 3–5 495 18 (15–21) 18
2009–2011 6–19 1955 16 (15–17) 16
2009–2011 20–79, Females 1937 16 (15–17) 16
2009–2011 20–79, Males 1676 14 (13–15) 14
Mercury
(total)
2012–2013 3–5 262 1.5E (0.67–2.3) 1.5⊥
2012–2013 6–19 1152 1.2 (1.1–1.4) 1.2
2012–2013 20–79 1229 2.3E (1.1–3.5) 2.3⊥
Methylmercury 2012–2013 20–79 416 0.2 (0.14–0.29) 0.2*
Molybdenum 2009–2011 3–5 495 2.7E (1.4–4.0) 2.7⊥
2009–2011 6–19 985 1.7 (1.3–2.0) 1.7
2009–2011 20–79 1759 1.6 (1.4–1.7) 1.6
Nickel 2009–2011 3–79 5924 1.1 (0.85–1.3) 1.1
Selenium 2009–2011 3–5 494 200 (200–210) 200
2009–2011 6–19 1953 220 (210–230) 220
2009–2011 20–79 3598 240 (230–250) 240
Zinc  2009–2011 3–5, Females 242 5800 (5500–6000) 5800
2009–2011 3–5, Males 253 5500 (5200–5800) 5500
2009–2011 6–19, Females 473 6500 (6300–6700) 6500
2009–2011 6–19, Males 514 6800 (6100–7500) 6800
2009–2011 20–79, Females 947 6700 (6500–7000) 6700
2009–2011 20–79, Males 821 7900 (7400–8300) 7900
P ution
b riation
•
•
•
•
•95: 95th percentile; *To convert to g Hg/L divide RV95 by 1.076; EUse data with ca
etween 16.6% and 33%; ⊥Provisional reference values due to high coefﬁcient of va
Variations in partitioning and exclusion criteria based on study
requirements/limitations while creating the reference popula-
tion. It is also not explicit if extreme values have been removed
prior to deriving RV95s in other studies.
National versus regional focus of the study. Some of the interna-
tional studies are focused on speciﬁc regions of the country (e.g.
Sao Paulo, Brazil; Kuno et al., 2013).
Deﬁnition of the age groups. These are not deﬁned consistently
between studies.
In the comparisons presented below, we compared only point
estimates of RV95 from studies as the associated 95% conﬁdence
intervals are not always available.Please cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
Chemical concentrations in a given population tend to change
over time. The time periods at which the biomonitoring data were
generated do not always align among studies. as the coefﬁcient of variation at the 95th percentile for the reference population is
.
To the best of our knowledge, this is the ﬁrst report to present
RV95s for methylmercury, selenium, and copper in blood as well
as DMA, cesium, and ﬂuoride in urine. Comparing the RV95s for
other metals and trace elements derived for the Canadian popu-
lation (Tables 4a and 4b) with other countries (Tables 5a and 5b),
we observed that the blood total arsenic RV95s for adults in Canada
are much lower than the blood arsenic RV95 reported in the adult
population in Brazil and Italy (Alimonti et al., 2011; Freire et al.,
2015). The urinary total arsenic RV95 for the Canadian popula-
tion is higher than that reported in Germany but lower than those
reported from Belgium and the Republic of Korea (Hoet et al., 2013;
Lee et al., 2012). Diet (particularly consumption of meat and ﬁsh)an biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
is the major source of exposure to arsenic in the general popu-
lation (Environment Canada & Health Canada, 1993). One  could
speculate that the differences in the diet as well as the concen-
tration of arsenic in ﬁsh and meat products between countries
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Table  4b
Reference values (RV95) for metals and trace elements in urine for the general Canadian population based on human biomonitoring data from the Canadian Health Measures
Survey.
Chemical Years Group (years) N P95 (95% CI) (g/L) RV95 (g/L)
Antimony 2009–2011 3–79 5576 0.17 (0.15–0.19) 0.17
Arsenic (total) 2009–2011 3–79 2480 27 (20–34) 27
Cadmium 2009–2011 3–5 457 0.69 (0.59–0.79) 0.69
2009–2011 6–19 892 0.68 (0.60–0.76) 0.68
2009–2011 20–79 1196 1.3 (1.1–1.5) 1.3
Cesium 2009–2011 3–79 5606 12 (11–14) 12
Copper 2009–2011 3–5 469 29 (25–32) 29
2009–2011 6–19 989 25 (23–27) 25
2009–2011 20–79 1513 25 (22–28) 25
Dimethylarsenic
acid  (DMA)*
2012–2013 3–5 225 12 (8.8–15) 12
2012–2013 6–19 538 9.7E (5.9–14) 9.7⊥
2012–2013 20–79 345 9.5 (7.9–11) 9.5
Fluoride** 2012–2013 3–5 362 1300 (1100–1500) 1300
2012–2013 6–19 481 1100 (790–1300) 1100
2012–2013 20–79 414 1400E (790–1900) 1400⊥
Lead 2009–2011 3–5 468 1.7 (1.3–2.1) 1.7
2009–2011 6–19 1920 1.3 (1.2–1.4) 1.3
2009–2011 20–79 3210 1.9 (1.8–2.1) 1.9
Mercury
(inorganic)
2012–2013 3–5 214 0.58E (0.29–0.87) 0.58⊥
2012–2013 6–19 522 F NA
2012–2013 20–79, Females 241 F NA
2012–2013 20–79, Males 217 0.73 (0.62–0.84) 0.73
Molybdenum 2009–2011 3–5 468 290 (200–380) 290
2009–2011 6–19 993 230 (180–290) 230
2009–2011 20–79 1519 170 (130–210) 170
Nickel 2009–2011 3–79 5602 4.4 (3.8–5.0) 4.4
Selenium 2009–2011 3–5 469 140 (120–160) 140
2009–2011 6–19 1925 140 (130–150) 140
2009–2011 20–79 3211 120 (110–130) 120
Thallium 2009–2011 3–5 468 0.64 (0.48–0.80) 0.64
2009–2011 6–19 1924 0.59 (0.53–0.64) 0.59
2009–2011 20–79 3207 0.61 (0.52–0.69) 0.61
Zinc  2009–2011 3–79 2980 1100 (990–1200) 1100
N ultipl
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fA: Not available; P95: 95th percentile; *Unit: g As/L. To convert the unit to g/L, m
t  the 95th percentile for the reference population is between 16.6% and 33%; vari
igh  (>33%) to be published; ⊥Provisional reference values due to high coefﬁcient o
ight contribute to the observed differences in the total arsenic
V95s. In addition, we excluded Canadians who consumed seafood
3 times per month while deriving total arsenic RV95s whereas
tudies from Brazil and Italy did not exclude participants based
n seafood consumptions. Such differences in the study design as
ell as laboratory methods used for sample analyses are expected
o contribute to the differences observed in total arsenic RV95s in
anada and those in other countries.
We  observed that the blood cadmium RV95 in Canadian children
s in the same range as that of Germany but lower than that from
zech Republic (Cˇerná et al., 2012). The blood cadmium RV95 in
anadian adults was lower than that reported from Germany, Czech
epublic, Italy, and the Republic of Korea but slightly higher than
hat reported for Brazil. The urinary cadmium RV95 for children
n Canada is higher than that from Germany but lower than that
rom the Czech Republic (Table 5b). The cadmium RV95 for adults
n Canada is lower than that for the Republic of Korea, but higher
han that from Germany, Belgium, and Spain. In general, cadmium
evels in blood provide an indication of recent exposures while lev-
ls in urine are an indicator of longer-term exposure (Adams and
ewcomb, 2014). A recent analysis of the CHMS data has shown
hat current and former smokers (based upon self-reporting) had
igher blood and urinary cadmium than never-smokers which is
onsistent with existing literature (Garner and Levallois, 2016). In
on-smokers (including never-smokers and former smokers), the
rimary non-occupational source of cadmium exposure is throughPlease cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
he ingestion of food; higher cadmium body burdens have been cor-
elated with the consumption of organ meats and seafood in some
tudies (Garner and Levallois, 2016; IARC, 1993) The observed dif-
erences in cadmium RV95s between countries may  be the result ofy RV95 by 1.8423; **Unit: mg/L; EUse data with caution as the coefﬁcient of variation
FCoefﬁcient of variation at the 95th percentile for the reference population is too
tion.
varying proportions of former smokers in the reference populations
and/or differences in diet composition.
The blood total mercury RV95 derived in Canadian children is
higher than those reported in Germany but lower than that from
the Czech Republic. However, the blood total mercury RV95 for the
adult population in Canada is lower than the respective populations
from Brazil, Italy and the Republic of Korea, but similar to Germany
and the Czech Republic (Table 5a). The urinary inorganic mercury
RV95 for young children in Canada is higher than that of Germany
and much lower than that of the Czech Republic. On  the other hand,
the RV95 for urinary inorganic mercury in male adults in Canada
are lower in comparison with the RV95 for the adult population
in other countries (Table 5b). In the general population, mercury
exposure occurs primarily through the consumption of seafood in
which methylmercury is the predominant form, and to a much
lesser extent, exposure to inorganic mercury may come from dental
amalgams and other sources (Health Canada, 2007). In blood, total
mercury levels are accepted as a reasonable measure of methylmer-
cury exposure. The lower Canadian, Czech Republic and German
total mercury levels in adults may  be attributed to the more strin-
gent exclusion criteria for seafood consumption (e.g. consumption
>3 times per month) than those used in the other countries (e.g.
no criteria, consumption within 72 h of sample collection). Simi-
larly, differences in exclusion criteria applied to inorganic mercury
concentrations may  also explain variations seen between countries.
We observed that the blood lead RV95s derived in Canada arean biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
between two- and seven-fold lower than those reported in respec-
tive sub-populations in other countries (Table 5a). In addition, the
urinary lead RV95 for Canadian adults is lower in comparison with
the adult population from Belgium (Hoet et al., 2013). Following
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Table  5a
International comparison of reference values (RV95) for metals in blood.
Country: Survey Study period Population (years) N Exclusion criteria RV95 (g/L) Reference
Arsenic (total)
Brazil 2010–2011 18–65 1183 9.87 Freire et al. (2015)
Italy: PROBE 2008–2010 18–65 1423 5.32 Alimonti et al. (2011)
Cadmium
Brazil 2010–2011 18–65 1059 A 0.65 Freire et al. (2015)
Czech Republic: HBM project 2005–2009 8–10 723 0.5 Cˇerná et al. (2012)
Czech Republic: HBM project 2005–2009 18–58 896 A 1.0 Cˇerná et al. (2012)
Germany: GerES IV 2003–2006 3–14 1498 A <0.3 Schulz et al. (2009)
Germany: GerES III 1997–1999 18–69 3061 A 1.0 Wilhelm et al. (2004)
Italy: PROBE 2008–2010 18–65 831 A 1.08 Alimonti et al. (2011)
Korea: KNHANES III 2005 ≥20 1025 A 2.94 Kim and Lee (2011)
Cobalt
Italy: PROBES 2008–2010 18–65 1423 0.443 Alimonti et al. (2011)
Lead
Brazil 2006 18–65 539 66 Kuno et al. (2013)
Czech Republic: HBM project 2005–2009 2–10 723 45 Cˇerná et al. (2012)
Czech Republic: HBM project 2001–2003 18–58 1188 75 Batáriová et al. (2006)
Germany: GerES IV 2003–2006 3–14 1560 35 Schulz et al. (2009)
Germany: GerES III 1997–1999 18–69, Females 2303 70 Wilhelm et al. (2004)
Germany: GerES III 1997–1999 18–69, Males 2342 90 Wilhelm et al. (2004)
Italy: PROBE 2008–2010 18–65 1423 51.7 Alimonti et al. (2011)
Korea: KorSEP III 2008 ≥20 5087 42.3 Lee et al. (2012)
Spain: BIOAMBIENT.ES 2009 18–65 1880 56.8 Can˜as et al. (2014)
Manganese
Brazil 2010–2011 18–65, Females 293 30.96 Freire et al. (2015)
Brazil 2010–2011 18–65, Males 890 29.30 Freire et al. (2015)
Italy: PROBE 2008–2010 18–65, Females 470 14.8 Alimonti et al. (2011)
Italy: PROBE 2008–2010 18–65, Males 953 14.1 Alimonti et al. (2011)
Korea: KorSEP III 2008 ≥20 years, Females 3531 21.9 Lee et al., 2012
Korea: KorSEP III 2008 ≥20 years, Males 1556 17.5 Lee et al. (2012)
Mercury (total)
Brazil 2006 18–65 593 4 Kuno et al. (2013)
Czech Republic: HBM project 2005–2009 8–10 723 1.4 Cˇerná et al. (2012)
Czech Republic: HBM project 2005–2009 18–58 1221 B 2.6 Cˇerná et al. (2012)
Germany: GerES IV 2003–2006 3–14 891 C 0.8 Schulz et al. (2009)
Germany: GerES III 1997–1999 18–69 2310 C 2.0 Wilhelm et al. (2004)
Italy: PROBE 2008–2010 18–65 1423 5.16 Alimonti et al. (2011)
Korea: KorSEP III 2008 ≥20 1963 D 9.42 Lee et al. (2012)
Molybdenum
Italy: PROBE 2008–2010 18–65 1423 2.05 Alimonti et al. (2011)
Nickel
Italy: PROBE 2008–2010 18–65 1422 2.62 Alimonti et al. (2011)
A: smoking; B: average ﬁsh consumption of ≥1 time per week; C: average ﬁsh consumption of >3 times per month; D: ﬁsh consumption within 72 h of sample collection.
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dotes:  BIOAMBIENT.ES = Human biomonitoring study of environmental pollutan
BM  = Human biomonitoring; KorSEP = Korea national survey for environmental poll
urvey;  PROBE = Programme for biomonitoring general population exposure.
arious risk management activities in Canada including the phase
ut of leaded gasoline and the reduction of lead content in paint and
urface coatings, the main route of exposure for the general adult
opulation is from ingestion of food and drinking water (Health
anada, 2013a). Similar regulatory activities in both Canada and the
nited States resulted in a consistent decline in blood lead levels in
he general population over the past decade. Regulatory limits for
ead in products set by countries varies widely. For example, Canada
nd the United States both limit lead content in paint to 90 ppm,
hile Brazil and the Republic of Korea have limits of 600 ppm; in
he European Union (including Germany, Italy and Spain), no con-
entration limit has been set for the amount of lead contained in
aint but rather restrictions have been placed on the use of certain
ead compounds (UNEP, 2016). These regulatory differences as well
s variations in the prevalence of lead pipes for drinking water mayPlease cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
e responsible for some of the differences seen internationally for
ead levels.
The blood nickel RV95 reported in Italy was higher than that
erived in Canada (Alimonti et al., 2011). However, the urinaryformed in Spain at the national level; GerES = German Environmental Survey;
s in the human body; KNHANES = Korean National Health and Nutrition Examination
nickel RV95 derived in Canada is similar to that reported in Germany
and Belgium (Hoet et al., 2013; Schulz et al., 2009).
The blood molybdenum RV95 decreases with age from 2.7 g/L
(provisional) in young children to 1.6 g/L in adults (Table 4a). The
urinary molybdenum RV95s show a similar decrease with age from
290 g/L in young children to 170 g/L in adults (Table 4b). The
blood molybdenum RV95 in Canadian adults is lower than that
reported from Italy and the urinary molybdenum RV95 in Canadian
adults is higher than that reported from Belgium (Table 5b).
The RV95s for blood manganese in different age groups in Cana-
dians ranged from 14 g/L in adult males to 18 g/L in young
children. We  also observed that the blood manganese RV95 in males
was lower than in females in the adult age group. The blood man-
ganese RV95s for adults in Canada is in the same range as those
from Italy but lower than those from Brazil and the Korean Repub-an biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
lic (Table 5a). We  could not locate any corresponding RV95s for
children.
The blood cobalt RV95 in Canada is lower than that for the adult
population in Italy. The urinary antimony RV95 in Canadians is
ARTICLE IN PRESSG ModelIJHEH-12996; No. of Pages 12
10 G. Saravanabhavan et al. / International Journal of Hygiene and Environmental Health xxx (2016) xxx–xxx
Table  5b
International comparison of reference values (RV95) for metals in urine.
Country: Survey Study Period Group (years) N Exclusion criteria RV95 (g/L) Reference
Antimony
Germany: GerES IV 2003–2006 3–14 1729 A 0.3 Schulz et al. (2009)
Belgium 2010–2011 >18 1001 B 0.236 Hoet et al. (2013)
Arsenic (total)
Germany: GerES IV 2003–2006 3–14 1487 A, C 15 Schulz et al. (2009)
Germany: GerES III 1997–1999 18–69 3924 A, C 15 Wilhelm et al. (2004)
Belgium 2010–2011 >18 1001 B, D 48.8 Hoet et al. (2013)
Korea: KorSEP III 2008 ≥20 1814 A, E 106.1 Lee et al. (2012)
Cadmium
Czech Republic: HBM project 2005–2009 8–10 723 1.0 Cˇerná et al. (2012)
Czech Republic: HBM project 2005–2009 18–58 896 F 1.3 Cˇerná et al. (2012)
Germany: GerES IV 2003–2006 3–14 1667 A, F 0.2 Schulz et al. (2009)
Germany: GerES III 1997–1999 18–69 3128 A, F 0.8 Wilhelm et al. (2004)
Belgium 2010–2011 >18 620 B, F 0.708 Hoet et al. (2013)
Korea: KorSEP III 2008 ≥20 4088 A, F 3.09 Lee et al. (2012)
Spain: BIOAMBIENT.ES 2009 18–65 691 F 0.74 López-Herranz et al. (2016)
Copper
Belgium 2010–2011 >18 1001 B 19.6 Hoet et al. (2013)
Lead
Belgium 2010–2011 >18 1001 B 2.81 Hoet et al. (2013)
Mercury (inorganic)
Czech Republic: HBM project 2005–2009 8–10 723 3 Cˇerná et al. (2012)
Czech Republic: HBM project 2005–2009 18–58 1227 9 Cˇerná et al. (2012)
Germany: GerES IV 2003–2006 3–14 1612 A, G 0.4 Schulz et al. (2009)
Germany: GerES III 1997–1999 18–69 1560 A, G 1.0 Wilhelm et al. (2004)
Belgium 2010–2011 >18 1001 B 1.88 Hoet et al. (2013)
Molybdenum
Belgium 2010–2011 >18 1001 B 116 Hoet et al. (2013)
Nickel
Germany: GerES IV 2003–2006 3–14 1567 4.5 Schulz et al. (2009)
Germany Not speciﬁed Adultsa Not speciﬁed 3.0 Wilhelm et al. (2004)
Belgium 2010–2011 >18 1001 B 4.73 Hoet et al. (2013)
Selenium
Belgium 2010–2011 >18 1001 B 61.6 Hoet et al. (2013)
Thallium
Germany: GerES IV 2003–2006 3–14 1729 0.6 Schulz et al. (2009)
Germany: ESB 2000–2008 20–29 Not speciﬁed 0.5 HBM Commission (2011)
Belgium 2010–2011 >18 1001 B 0.500 Hoet et al. (2013)
Zinc
Belgium 2010–2011 >18 1001 B 1048 Hoet et al. (2013)
A: creatinine levels <0.3 or >3.0 g/L; B: occupational exposure; C: ﬁsh consumption 48 h prior to sample collection; D: ﬁsh consumption within 96 h of sample collection; E:
ﬁsh  consumption within 72 h of sample collection; F: smoking; G: presence of dental amalgam ﬁllings.
N nts pe
G ea na
l
a
i
p
S
t
(
n
g
s
U
C
S
c
H
n
M
l
Botes:  BIOAMBIENT.ES = Human biomonitoring study of environmental polluta
erES  = German Environmental Survey; HBM = Human biomonitoring; KorSEP = Kor
a Not a strictly representative sample, based upon literature data.
ower than that reported in German children as well as Belgian
dult populations. The urinary selenium RV95 in Canadian adults
s approximately twice that reported in the corresponding Belgian
opulation (Table 5b). Selenium concentrations in the adult United
tates population, measured in NHANES 2011–2012, are similar
o concentrations in Canadians, measured in CHMS 2009–2011
CDC, 2015b; Health Canada, 2013b). The primary route of sele-
ium exposure is through ingestion with cereals (breads, baked
oods, cereal, grains and ﬂours) comprising the main sources of
elenium exposure for the general population in Canada and the
nited States (Chun et al., 2010; Environment Canada & Health
anada, 2015). Although selenium intakes vary across the United
tates and Canada, it is considered that the general populations
onsume adequate amounts of selenium (Environment Canada &
ealth Canada, 2015; NIH, 2016). Conversely, it is generally recog-Please cite this article in press as: Saravanabhavan, G., et al., Hum
ments in blood and urine derived from the Canadian Health Mea
http://dx.doi.org/10.1016/j.ijheh.2016.10.006
ised that selenium intakes across Europe are low (Stoffaneller and
orse, 2015). These differences in intake levels between countries
ikely contribute to the differences observed between Canadian and
elgian RV95s.rformed in Spain at the national level; ESB = Environmental Specimen Bank;
tional survey for environmental pollutants in the human body.
We  noted that the blood zinc RV95s in male children and adults
are higher than for females; however, in young children the RV95 for
females is higher than for males. The urinary zinc RV95 in Canadians
is in the same range as that reported in the Belgian adult population
(Table 5b). The blood copper RV95s for Canadian males were lower
than females (Table 4a). In the case of urinary copper, the RV95 in
Canadian adults is higher than that reported in the adult population
from Belgium (Table 5b).
Based on the chemical, we  observed differences between RV95s
generated in this study with those from other countries. However,
as mentioned earlier, prior to deriving conclusions on the extent
of exposure based on RV95 comparisons, several factors need to
be considered. It should be noted that the RV95s are statistically
based exposure values to reﬂect background exposure levels (after
excluding major confounding factors) and are not health or toxico-an biomonitoring reference values for metals and trace ele-
sures Survey 2007–2013. Int. J. Hyg. Environ. Health (2016),
logically based. Therefore, RV95s by themselves cannot be used to
predict health effects at the individual or population level. More-
over, RV95s inherit all the basic characteristics of the biomonitoring
data from which they were derived. For example, the robustness
 ING ModelI
 Hygie
o
b
i
a
c
l
s
4
u
l
C
t
d
t
n
t
i
p
p
w
F
c
A
v
G
t
v
C
a
R
A
A
A
A
A
A
A
A
A
A
A
AARTICLEJHEH-12996; No. of Pages 12
G. Saravanabhavan et al. / International Journal of
f the analytical method employed as well as the quality of the
iomonitoring data play a signiﬁcant role in determining the valid-
ty of the RV95s. Moreover, the uncertainties associated with RV95s
re governed by several factors and may  vary from chemical to
hemical. Finally, RV95s need to be periodically updated using the
atest biomonitoring dataset to account for any changes in the expo-
ure pattern over time.
. Conclusion
In this work, we derived RV95s for 15 metals and trace elements
sing the concentration of speciﬁc biomarkers in appropriate bio-
ogical matrices based on the latest biomonitoring data from the
HMS. Exclusion and partitioning criteria were derived and used
o construct reference populations for each chemical. The RV95s
erived in this work represent the ﬁrst RV95 dataset for metals and
race elements for the general Canadian population. It should be
oted that these RV95s are strictly indicators of exposure; as the
oxicological information of the environmental chemicals is not
ncorporated in their derivation, these values cannot be used to
redict any adverse health outcomes in individuals or the general
opulation. Nonetheless, they provide a reference point against
hich individual and population HBM results can be compared.
uture work is underway to derive RV95s for other environmental
hemicals included in the CHMS.
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